Discovery & Development

Scientists unearth new molecular targets on AT1R that could lead to improved drugs for heart disease

The COVID-19 pandemic has helped propel the RNA field forward, but manufacturing and funding challenges lie ahead.

Researchers are working on ways to introduce nanoscale artificial life-forms to viruses with the aim of mimicking the human immune system

Sulforaphane has therapeutic potential in numerous areas but formulation is key. Can enteric coatings help find the way forward?

New antibiotic candidate Clovibactin eliminates bacteria without developing resistance

Will our generation be the last to face untreatable Alzheimer’s disease? With predictive biomarkers and active immunotherapies, just maybe.

Here’s why virus-like particles could open a new chapter in combating disease.

Scientists are targeting EV-A71 RNA viruses using an adeno-associated virus-delivered CRISPR-Cas13 editor

In light of cabotegravir’s positive opinion for sexually acquired HIV-1, I wanted to explore the history and politics of HIV/AIDS drug development

Katalin Karikó and Drew Weissman win prestigious prize for persevering in a field that many ignored.